Cargando…
Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation
Human pluripotent stem cells (hPSCs) have promising therapeutic applications due to their infinite capacity for self-renewal and pluripotency. Genomic stability is imperative for the clinical use of hPSCs; however, copy number variation (CNV), especially recurrent CNV at 20q11.21, may contribute gen...
Autores principales: | Jo, Hye-Yeong, Lee, Youngsun, Ahn, Hongryul, Han, Hyeong-Jun, Kwon, Ara, Kim, Bo-Young, Ha, Hye-Yeong, Kim, Sang Cheol, Kim, Jung-Hyun, Kim, Yong-Ou, Kim, Sun, Koo, Soo Kyung, Park, Mi-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596514/ https://www.ncbi.nlm.nih.gov/pubmed/33122739 http://dx.doi.org/10.1038/s41598-020-75657-7 |
Ejemplares similares
-
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
por: Kim, Jung-Hyun, et al.
Publicado: (2022) -
An Interstitial 20q11.21 Microdeletion Causing Mild Intellectual Disability and Facial Dysmorphisms
por: Iourov, Ivan Y., et al.
Publicado: (2013) -
Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in Colorectal Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2021) -
Nanopore Sequencing Indicates That Tandem Amplification of Chromosome 20q11.21 in Human Pluripotent Stem Cells Is Driven by Break-Induced Replication
por: Halliwell, Jason A., et al.
Publicado: (2021) -
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
por: Bodbin, Sara E., et al.
Publicado: (2020)